Cargando…

Evaluation of grading and hormone receptor immunostaining on fine needle aspirates in carcinoma breast

BACKGROUND: Grading and hormone receptor determination in breast carcinoma are predictive factors for response to hormonal therapy. AIM: This study was undertaken to grade breast carcinoma and to determine estrogen receptor (ER) and progesterone receptor (PR) expression on fine-needle aspiration cyt...

Descripción completa

Detalles Bibliográficos
Autores principales: Handa, Uma, Kumar, Amit, Kundu, Reetu, Dalal, Usha, Mohan, Harsh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4408669/
https://www.ncbi.nlm.nih.gov/pubmed/25948935
http://dx.doi.org/10.4103/0970-9371.155222
_version_ 1782368084887076864
author Handa, Uma
Kumar, Amit
Kundu, Reetu
Dalal, Usha
Mohan, Harsh
author_facet Handa, Uma
Kumar, Amit
Kundu, Reetu
Dalal, Usha
Mohan, Harsh
author_sort Handa, Uma
collection PubMed
description BACKGROUND: Grading and hormone receptor determination in breast carcinoma are predictive factors for response to hormonal therapy. AIM: This study was undertaken to grade breast carcinoma and to determine estrogen receptor (ER) and progesterone receptor (PR) expression on fine-needle aspiration cytology (FNAC). Furthermore, the objective was to compare the results with histological grading and immunohistochemistry on surgical material. MATERIALS AND METHODS: Fifty cases of breast carcinoma diagnosed on FNAC were included. The cytological grading was done according to the Robinson's grading system. The corresponding histology sections were graded using the modified Bloom-Richardson system. Immunostaining for ER and PR was done on smears and tissue sections. RESULTS: On both cytological and histological evaluation, 49 cases were infiltrating ductal carcinoma and one case was colloid carcinoma. On comparing cytological and histological grading, 78% were correctly graded on cytology. The sensitivity, specificity, positive predictive value and negative predictive value for ER detection on immunocytochemistry (ICC) were 55.6%, 95%, 93.8% and 61.3%, respectively. The sensitivity, specificity, positive and negative predictive value for PR detection on ICC were 57.7%, 95.2%, 93.8% and 64.5%, respectively. The correlation for ER and PR between cytology and histology was 72.3% and 74.5%. CONCLUSION: The grading along with ER and PR immunostaining of breast carcinoma on smears is advocated because of high concordance between cytology and histology. This allows the patient to be treated with hormonal therapy on the basis of FNAC alone.
format Online
Article
Text
id pubmed-4408669
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Medknow Publications & Media Pvt Ltd
record_format MEDLINE/PubMed
spelling pubmed-44086692015-05-06 Evaluation of grading and hormone receptor immunostaining on fine needle aspirates in carcinoma breast Handa, Uma Kumar, Amit Kundu, Reetu Dalal, Usha Mohan, Harsh J Cytol Original Article BACKGROUND: Grading and hormone receptor determination in breast carcinoma are predictive factors for response to hormonal therapy. AIM: This study was undertaken to grade breast carcinoma and to determine estrogen receptor (ER) and progesterone receptor (PR) expression on fine-needle aspiration cytology (FNAC). Furthermore, the objective was to compare the results with histological grading and immunohistochemistry on surgical material. MATERIALS AND METHODS: Fifty cases of breast carcinoma diagnosed on FNAC were included. The cytological grading was done according to the Robinson's grading system. The corresponding histology sections were graded using the modified Bloom-Richardson system. Immunostaining for ER and PR was done on smears and tissue sections. RESULTS: On both cytological and histological evaluation, 49 cases were infiltrating ductal carcinoma and one case was colloid carcinoma. On comparing cytological and histological grading, 78% were correctly graded on cytology. The sensitivity, specificity, positive predictive value and negative predictive value for ER detection on immunocytochemistry (ICC) were 55.6%, 95%, 93.8% and 61.3%, respectively. The sensitivity, specificity, positive and negative predictive value for PR detection on ICC were 57.7%, 95.2%, 93.8% and 64.5%, respectively. The correlation for ER and PR between cytology and histology was 72.3% and 74.5%. CONCLUSION: The grading along with ER and PR immunostaining of breast carcinoma on smears is advocated because of high concordance between cytology and histology. This allows the patient to be treated with hormonal therapy on the basis of FNAC alone. Medknow Publications & Media Pvt Ltd 2015 /pmc/articles/PMC4408669/ /pubmed/25948935 http://dx.doi.org/10.4103/0970-9371.155222 Text en Copyright: © Journal of Cytology http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Handa, Uma
Kumar, Amit
Kundu, Reetu
Dalal, Usha
Mohan, Harsh
Evaluation of grading and hormone receptor immunostaining on fine needle aspirates in carcinoma breast
title Evaluation of grading and hormone receptor immunostaining on fine needle aspirates in carcinoma breast
title_full Evaluation of grading and hormone receptor immunostaining on fine needle aspirates in carcinoma breast
title_fullStr Evaluation of grading and hormone receptor immunostaining on fine needle aspirates in carcinoma breast
title_full_unstemmed Evaluation of grading and hormone receptor immunostaining on fine needle aspirates in carcinoma breast
title_short Evaluation of grading and hormone receptor immunostaining on fine needle aspirates in carcinoma breast
title_sort evaluation of grading and hormone receptor immunostaining on fine needle aspirates in carcinoma breast
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4408669/
https://www.ncbi.nlm.nih.gov/pubmed/25948935
http://dx.doi.org/10.4103/0970-9371.155222
work_keys_str_mv AT handauma evaluationofgradingandhormonereceptorimmunostainingonfineneedleaspiratesincarcinomabreast
AT kumaramit evaluationofgradingandhormonereceptorimmunostainingonfineneedleaspiratesincarcinomabreast
AT kundureetu evaluationofgradingandhormonereceptorimmunostainingonfineneedleaspiratesincarcinomabreast
AT dalalusha evaluationofgradingandhormonereceptorimmunostainingonfineneedleaspiratesincarcinomabreast
AT mohanharsh evaluationofgradingandhormonereceptorimmunostainingonfineneedleaspiratesincarcinomabreast